Jennison Associates
PTLA

Jennison Associates’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Jennison Associates’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,588
Closed -$277K – 743
2019
Q4 		$277K Buy
+11,588
New +$320K ﹤0.01% 615
2016
Q1 		– Sell
-858,523
Closed -$44.2M – 681
2015
Q4 		$44.2M Buy
858,523
+203,505
+31% +$9.87M 0.04% 305
2015
Q3 		$27.9M Buy
655,018
+5,118
+0.8% +$247K 0.03% 391
2015
Q2 		$29.6M Buy
649,900
+6,543
+1% +$263K 0.03% 412
2015
Q1 		$24.4M Buy
643,357
+2,058
+0.3% +$70.7K 0.02% 424
2014
Q4 		$18.2M Sell
641,299
-706
-0.1% -$19.6K 0.02% 446
2014
Q3 		$16.2M Buy
642,005
+959
+0.1% +$25.3K 0.02% 452
2014
Q2 		$18.7M Sell
641,046
-76,170
-11% -$1.84M 0.02% 435
2014
Q1 		$18.6M Sell
717,216
-353,864
-33% -$9.44M 0.02% 447
2013
Q4 		$27.6M Sell
1,071,080
-7,714
-0.7% -$187K 0.03% 410
2013
Q3 		$28.9M Sell
1,078,794
-6,980
-0.6% -$166K 0.03% 394
2013
Q2 		$26.7M Buy
+1,085,774
New +$21.6M 0.03% 391

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Jennison Associates's PTLA Position: Q1 2020 in Review

Jennison Associates sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 11,588 shares — an estimated $277K sold.

Jennison Associates first reported a position in PTLA in Q2 2013 and held it in 12 quarters. The position peaked at $44.2M in Q4 2015. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • Jennison Associates reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Jennison Associates sold 11,588 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $277K.
  • Jennison Associates first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 12 quarters.
  • Jennison Associates's Portola Pharmaceuticals, Inc. position peaked at $44.2M in Q4 2015.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Jennison Associates's 13F filing for Q1 2020, filed 6 May 2020.